Obeid Rima, Herrmann Wolfgang
Department of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, University Hospital of Saarland, Kirrberger Strasse, Gebäude 57, 66421 Homburg/Saar, Germany.
FEBS Lett. 2006 May 29;580(13):2994-3005. doi: 10.1016/j.febslet.2006.04.088. Epub 2006 May 6.
Mild to moderate hyperhomocysteinemia is a risk factor for neurodegenerative diseases. Human studies suggest that homocysteine (Hcy) plays a role in brain damage, cognitive and memory decline. Numerous studies in recent years investigated the role of Hcy as a cause of brain damage. Hcy itself or folate and vitamin B12 deficiency can cause disturbed methylation and/or redox potentials, thus promoting calcium influx, amyloid and tau protein accumulation, apoptosis, and neuronal death. The Hcy effect may also be mediated by activating the N-methyl-D-aspartate receptor subtype. Numerous neurotoxic effects of Hcy can be blocked by folate, glutamate receptor antagonists, or various antioxidants. This review describes the most important mechanisms of Hcy neurotoxicity and pharmacological agents known to reverse Hcy effects.
轻度至中度高同型半胱氨酸血症是神经退行性疾病的一个危险因素。人体研究表明,同型半胱氨酸(Hcy)在脑损伤、认知和记忆衰退中起作用。近年来,大量研究调查了Hcy作为脑损伤病因的作用。Hcy本身或叶酸和维生素B12缺乏可导致甲基化和/或氧化还原电位紊乱,从而促进钙内流、淀粉样蛋白和tau蛋白积累、细胞凋亡及神经元死亡。Hcy的作用也可能通过激活N-甲基-D-天冬氨酸受体亚型来介导。叶酸、谷氨酸受体拮抗剂或各种抗氧化剂可阻断Hcy的多种神经毒性作用。本综述描述了Hcy神经毒性的最重要机制以及已知可逆转Hcy效应的药物制剂。